Ben Bronstein

CIK: 0001604458

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ALDX

Aldeyra Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

ALDX
Aldeyra Therapeutics, Inc.
Jun 9, 2026
Award(A)
Stock Option (Right to Buy)
Direct
70K shares-
ALDX
Aldeyra Therapeutics, Inc.
Jun 9, 2026
Award(A)
Stock Option (Right to Buy)
Direct
5.3K shares-
ALDX
Aldeyra Therapeutics, Inc.
Jun 9, 2026
Award(A)
Stock Option (Right to Buy)
Direct
5K shares-
ALDX
Aldeyra Therapeutics, Inc.
Jun 10, 2025
Award(A)
Stock Option (Right to Buy)
Direct
62.7K shares-
ALDX
Aldeyra Therapeutics, Inc.
Jun 10, 2025
Award(A)
Stock Option (Right to Buy)
Direct
3.6K shares-
ALDX
Aldeyra Therapeutics, Inc.
Jun 10, 2024
Award(A)
Stock Option (Right to Buy)
Direct
3.9K shares-

		Type	Shares	Price		Ownership
Jun 9, 2026	ALDX Aldeyra Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	70,000	-	-	Direct
Jun 9, 2026	ALDX Aldeyra Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	5,309	-	-	Direct
Jun 9, 2026	ALDX Aldeyra Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	4,977	-	-	Direct
Jun 10, 2025	ALDX Aldeyra Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	62,728	-	-	Direct
Jun 10, 2025	ALDX Aldeyra Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	3,619	-	-	Direct
Jun 10, 2024	ALDX Aldeyra Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	3,860	-	-	Direct

1-6 of 6 transactions

About Bronstein Ben

Bronstein Ben (SEC CIK 0001604458) files insider reports with the SEC as Director of Aldeyra Therapeutics, Inc. (ALDX).

Signal8 holds 2 ownership filings by Bronstein Ben, all Form 4s, filed between Jun 12, 2025 and Jun 11, 2026. Those filings report 6 transactions, from Jun 10, 2024 to Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Bronstein Ben's filings is in LEXINGTON, MA.

Recent filings by Bronstein Ben

Jun 9, 2026: Grants or awards of ALDX derivative securities (3 lines, Form 4, code A).
Jun 10, 2025: Grants or awards of ALDX derivative securities (2 lines, Form 4, code A).
Jun 10, 2024: Grant or award of ALDX derivative securities (Form 4, code A).

Other insiders filing for Aldeyra Therapeutics, Inc. (ALDX)

Miller-Rich Nancy, Director
DOUGLAS RICHARD, Director
Phillips Gary M., Director
Clark William D, Director
Walker Neal, Director
DEPTULA-HICKS DARLENE M, Director

How to read Form 4 transaction codes